Latest Breaking News On - Dana walker - Page 8 : comparemela.com

Bristol Myers combination therapy improves survival rate in colorectal cancer trial

Bristol Myers combination therapy improves survival rate in colorectal cancer trial
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Dana walkerBristol myers squibb

BMS s Opdivo-Yervoy excels in first-line colorectal cancer trial

BMS s Opdivo-Yervoy excels in first-line colorectal cancer trial
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Dana walkerBristol myers squibbBlinded independent central review

Nivolumab Plus Ipilimumab Improves PFS in Newly Diagnosed Metastatic Colorectal Cancer

The combination of nivolumab and ipilimumab led to a statistically significant and clinically meaningful improvement in progression-free survival per blinded independent central review compared with investigator’s choice of chemotherapy as frontline therapy in patients with metastatic colorectal cancer.

Dana walkerBristol myers squibbNivolumab and ipilimumabPatients with metastatic colorectal cancerCheckmate 8hw trial

FDA Grants Priority Review to Frontline Nivolumab Plus Chemo for Unresectable or Metastatic Urothelial Carcinoma

The FDA has granted priority review to a supplemental biologics license application seeking the approval of nivolumab plus cisplatin-based chemotherapy as a frontline treatment option for adult patients with unresectable or metastatic urothelial carcinoma.

United statesDana walkerBristol myers squibbPrescription drug user feeUrothelial carcinomaPriority reviewUnresectable or metastatic urothelial carcinoma

FDA Accepts Priority Review for Opdivo Plus Chemo in Bladder Cancer Subtype

The FDA accepted a priority review for the supplemental Biologics License Application of Opdivo with chemotherapy for untreated patients with unresectable or metastatic bladder cancer.

Dana walkerNational cancer instituteBristol myers squibbDrug administrationBiologics license applicationNational cancerBristol myersOpdivo plus chemo provides survival benefitBladder cancer